Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Kidney International

• Publication date

  1997-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/KI.1997.361PMID 9264010
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• IgA1 is the major immunoglobulin component of immune complexes in the acquired immune deficiency syndrome

  2004cited by this paper
• IgA-associated renal diseases: Antibodies to environmental antigens in sera and deposition of immunoglobulins and antigens in glomeruli

  2004cited by this paper
• Aberrant glycosylation of IgA from patients with IgA nephropathy

  1996cited by this paper
• Evaluation of monoclonal antibodies with specificity for human IgA, IgA subclasses and allotypes and secretory component. Results of an IUIS/WHO collaborative study.

  1996cited by this paper
• Abundance of Gal beta 1,3GalNAc in O-linked oligosaccharide on hinge region of polymerized IgA1 and heat-aggregated IgA1 from normal human serum.

  1996cited by this paper
• Polyethylene glycol precipitates of serum contain a large proportion of uncomplexed immunoglobulins and C3.

  1996cited by this paper
• Galactosylation of N‐ and O‐linked carbohydrate moieties of IgA1 and IgG in IgA nephropathy

  1995cited by this paper
• IgA nephropathy.

  1995cited by this paper
• O-linked oligosaccharide on IgA1 hinge region in IgA nephropathy. Fundamental study for precise structure and possible role.

  1995cited by this paper
• Alterations in the IgA carbohydrate chains influence the cellular distribution of IgA1.

  1995cited by this paper
• Glycosylation changes of IgG associated with rheumatooid arthritis can activate complement via the mannose-binding protein

  1995cited by this paper
• Carbohydrate heterogeneity of human myeloma proteins of the IgA1 and IgA2 subclasses.

  1994cited by this paper
• Lectin Receptors on IgA Isotypes

  1994cited by this paper
• The role of the carbohydrate chains in complement (C3) fixation by solid-phase-bound human IgA.

  1994cited by this paper
• Structural analysis of the N-glycans from human immunoglobulin A1: comparison of normal human serum immunoglobulin A1 with that isolated from patients with rheumatoid arthritis.

  1994cited by this paper
• Persistent repression of a functional allele can be responsible for galactosyltransferase deficiency in Tn syndrome.

  1993cited by this paper
• Defective galactosylation and clearance of IgA1 molecules as a possible etiopathogenic factor in IgA nephropathy.

  1993cited by this paper
• Biological roles of oligosaccharides: all of the theories are correct

  1993cited by this paper
• The pathogenic role of immunoglobulin A polymers in immunoglobulin A nephropathy.

  1993cited by this paper
• T cell clones with normal or defective O‐galactosylation from a patient with permanent mixed‐field polyagglutinability

  1992cited by this paper
• Absence of mesangial IgA in AIDS: a postmortem study.

  1991cited by this paper
• Impairment of jacalin binding to serum IgA in IgA nephropathy

  1990cited by this paper
• Site of Catabolism of Autologous and Heterologous IgA in Non‐Human Primates

  1990cited by this paper
• Cellular distribution, regulation, and biochemical nature of an Fc alpha receptor in humans

  1990cited by this paper
• Evolutionary hypervariability in the hinge region of the immunoglobulin alpha gene.

  1990cited by this paper
• Kinetic study of a galactosyltransferase in the B cells of patients with rheumatoid arthritis.

  1990cited by this paper
• Secretory immunoglobulin A carries oligosaccharide receptors for Escherichia coli type 1 fimbrial lectin

  1990cited by this paper
• O-linked oligosaccharides from human serum immunoglobulin A1.

  1989cited by this paper
• Clearance kinetics and fate of macromolecular IgA in patients with IgA nephropathy.

  1989cited by this paper
• Studies of aglycosylated chimeric mouse-human IgG. Role of carbohydrate in the structure and effector functions mediated by the human IgG constant region.

  1989cited by this paper
• Frequent association of mesangial glomerulonephritis and alcohol abuse: a study of 3 ethnic groups.

  1989cited by this paper
• IgA nephropathy: pathogenesis of the most common form of glomerulonephritis.

  1989cited by this paper
• Humoral immune response to influenza vaccination in patients with primary immunoglobulin A nephropathy. An analysis of isotype distribution and size of the influenza-specific antibodies.

  1989cited by this paper
• Occurrence of polymeric IgA1 rheumatoid factor in the acquired immune deficiency syndrome

  1988cited by this paper
• IgA nephropathy, the most common glomerulonephritis worldwide. A neglected disease in the United States?

  1988cited by this paper
• The sites of catabolism of murine monomeric IgA.

  1988cited by this paper
• Abnormal glycosylation of serum IgG from patients with chronic inflammatory diseases.

  1988cited by this paper
• Receptor-mediated binding and uptake of immunoglobulin A by human liver.

  1988cited by this paper
• Role of hepatocytes in the uptake of IgA and IgA-containing immune complexes in mice.

  1988cited by this paper
• Day-to-day variation of 24-hour intragastric acidity.

  1988cited by this paper
• Striking elevation of serum IgA, IgA-containing immune complexes, and IgA rheumatoid factor in clinically silent dermatitis herpetiformis.

  1987cited by this paper
• Reduced B-cell galactosyltransferase activity in rheumatoid arthritis.

  1987cited by this paper
• Polymeric IgA rheumatoid factor in idiopathic IgA mesangial nephropathy (Berger's disease).

  1986cited by this paper
• IgA subclasses.

  1986cited by this paper
• Circulating immune complexes and immunoglobulin A rheumatoid factor in patients with mesangial immunoglobulin A nephropathies.

  1986cited by this paper
• Immune complex hyperlipidemia induced by an apolipoprotein-reactive immunoglobulin A paraprotein from a patient with multiple myeloma. Characterization of this immunoglobulin.

  1985cited by this paper
• Carbohydrate-mediated clearance of secretory IgA from the circulation.

  1985cited by this paper
• [3] Immunoglobulin A (IgA)

  1985cited by this paper
• Jacalin: an IgA-binding lectin.

  1985cited by this paper
• Immunoglobulin A (IgA).

  1985cited by this paper
• [IgA nephropathy].

  1985cited by this paper
• IgA rheumatoid factor synthesis by dissociated synovial cells. Characterization and relationship to IgM rheumatoid factor synthesis.

  1985cited by this paper
• Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG

  1985cited by this paper
• Circulating IgA immune complexes in AIDS.

  1985cited by this paper
• Gas chromatographic analysis of lens monosaccharides.

  1984cited by this paper
• Structures of the O-glycosidically linked oligosaccharides of human IgD.

  1983cited by this paper
• Biological significance of carbohydrate chains on monoclonal antibodies.

  1983cited by this paper
• IgA interaction with the asialoglycoprotein receptor.

  1982cited by this paper
• Secretory component-dependent hepatic transport of IgA antibody-antigen complexes.

  1981cited by this paper
• IgA-containing circulating immune complexes in dermatitis herpetiformis, Henoch-Schönlein purpura, systemic lupus erythematosus and other diseases.

  1980cited by this paper
• Galactose and N-acetylgalactosamine-specific endocytosis of glycopeptides by isolated rat hepatocytes.

  1980cited by this paper
• Structure of the carbohydrate units of IgA1 immunoglobulin. II. Structure of the O-glycosidically linked oligosaccharide units.

  1974cited by this paper
• The purification and properties of beta-galactosidase from bovine testes.

  1973cited by this paper
• Partial duplication in the "hinge" region of IgA 1 myeloma proteins.

  1972cited by this paper
• An enzymic method for the trace iodination of immunoglobulins and other proteins.

  1969cited by this paper
• IgA glomerular deposits in renal disease.

  1969cited by this paper

• Kidney injury and colocalization of complement C3, IgA, and IgG in glomerular immune-complex deposits of patients with IgA nephropathy or IgA vasculitis with nephritis.

  2025cites this paper
• Emerging Biochemical and Immunologic Mechanisms in the Pathogenesis of IgA Nephropathy.

  2025cites this paper
• Complement-Mediated Kidney Diseases: Role of Alternative Pathway in Glomerular Inflammation

  2025cites this paper
• High-density lectin microarray uncovers stage-specific plasma glycoprofiling signatures for non-muscle-invasive and muscle-invasive bladder cancer

  2025cites this paper
• The road ahead: emerging therapies for primary IgA nephropathy

  2025cites this paper
• IgA Nephropathy and Glomerular Diseases Associated with Infection

  2025cites this paper
• Complement proteins associated with circulatory and glomerular IgA-containing immune complexes in patients with IgA nephropathy

  2025cites this paper
• 3D structural insights into the effect of N-glycosylation in human chitotriosidase variant G102S.

  2024cites this paper
• Intestinal epithelium dysfunctions cause IgA deposition in the kidney glomeruli of intestine-specific Ap1m2-deficient mice

  2024cites this paper
• Sparsentan ameliorates glomerular hypercellularity and inflammatory-gene networks induced by IgA1-IgG immune complexes in a mouse model of IgA nephropathy

  2024cites this paper
• Liquid Biopsy: A New Avenue for the Diagnosis of Kidney Disease: Diabetic Kidney Disease, Renal Cancer, and IgA Nephropathy

  2024cites this paper
• Correlation of Serum Galactose-Deficient IgA1 and Oxford Class in Cases of IgA Nephropathy.

  2024cites this paper
• Causal association between peripheral immune cells and IgA nephropathy: a Mendelian randomization study

  2024cites this paper
• Loss of GalNAc-T14 links O-glycosylation defects to alterations in B cell homing in IgA nephropathy

  2024cites this paper
• Contemporary review of IgA nephropathy

  2024cites this paper
• O-glycosylation of IgA1 and the pathogenesis of an autoimmune disease IgA nephropathy.

  2024cites this paper
• Pathogenesis of IgA nephropathy: Omics data inform glycomedicine

  2024cites this paper
• The pathogenesis of IgA nephropathy and implications for treatment

  2024cites this paper
• IgA nephropathy associated with Crohn's disease

  2023cites this paper
• Nonimmune binding of human immunoglobulins G and A by Streptococcus pyogenes: the role of this phenomenon in pathology

  2023cites this paper
• IgA nephropathy

  2023cites this paper
• IgA Nephropathy: the Lectin Pathway and Implications for Targeted Therapy.

  2023cites this paper
• Omics are Getting Us Closer to Understanding IgA Nephropathy

  2023influential citation
• The significance of galactose-deficient immunoglobulin A1 staining in kidney diseases with IgA deposition

  2023cites this paper
• The role of mononuclear phagocyte system in IgA nephropathy: pathogenesis and prognosis

  2023cites this paper
• IgA Nephropathy: Pleiotropic impact of Epstein-Barr virus infection on immunopathogenesis and racial incidence of the disease

  2023cites this paper
• Current Understanding of Complement Proteins as Therapeutic Targets for the Treatment of Immunoglobulin A Nephropathy

  2023cites this paper
• Anomalous kinetics of galactose-deficient IgA incurring nephropathy revealed by cross-scale optical imaging.

  2022cites this paper
• Increased retinal drusen in IgA glomerulonephritis are further evidence for complement activation in disease pathogenesis

  2022cites this paper
• Galactose-Deficient IgA1 B cells in the Circulation of IgA Nephropathy Patients Carry Preferentially Lambda Light Chains and Mucosal Homing Receptors

  2022cites this paper
• Racial heterogeneity of IgA1 hinge-region O-glycoforms in patients with IgA nephropathy

  2022cites this paper
• Cytokines and Production of Aberrantly O-Glycosylated IgA1, the Main Autoantigen in IgA Nephropathy

  2022cites this paper
• Streptococcus pyogenes: phenomenon of nonimmune binding of human immunoglobulins and its role in pathology

  2022cites this paper
• Crohn’s disease may promote inflammation in IgA nephropathy: a case–control study of patients undergoing kidney biopsy

  2022cites this paper
• Liuwei Dihuang Pills Inhibit Podocyte Injury and Alleviate IgA Nephropathy by Directly Altering Mesangial Cell-Derived Exosome Function and Secretion

  2022cites this paper
• Sialylation as an Important Regulator of Antibody Function

  2022cites this paper
• Single-cell RNA-sequencing reveals distinct immune cell subsets and signaling pathways in IgA nephropathy

  2021cites this paper
• Aberrantly Glycosylated IgA1 in IgA Nephropathy: What We Know and What We Don’t Know

  2021cites this paper
• Pathogenesis of IgA Nephropathy: Current Understanding and Implications for Development of Disease-Specific Treatment

  2021cites this paper
• Systolic blood pressure and chronic kidney disease progression in patients with primary glomerular disease

  2021cites this paper
• Immunoglobulin A Glycosylation and Its Role in Disease.

  2021cites this paper
• The immune landscape of IgA induction in the gut

  2021cites this paper
• Quantitative assessment of successive carbohydrate additions to the clustered O -glycosylation sites of IgA1 by glycosyltransferases

  2021cites this paper
• Plasma galactose-deficient immunoglobulin A1 and loss of kidney function in patients with immunoglobulin A vasculitis nephritis.

  2020cites this paper
• Juntendo Medical Journal

  2020cites this paper
• Analysis of O-glycoforms of the IgA1 hinge region by sequential deglycosylation

  2020cites this paper
• CDR3 sequences in IgA nephropathy are shorter and exhibit reduced diversity

  2020cites this paper
• LC-MS methods analyzing clustered O-glycosylation reactions.

  2020cites this paper
• IgA subclasses have different effector functions associated with distinct glycosylation profiles

  2020cites this paper
• Mass spectrometry for the identification and analysis of highly complex glycosylation of therapeutic or pathogenic proteins

  2020cites this paper
• Emerging Modes of Treatment of IgA Nephropathy

  2020cites this paper
• Multi-hit Pathogenesis of IgA Nephropathy

  2019cites this paper
• Evaluation of IgA1 O-glycosylation in Henoch-Schönlein Purpura Nephritis Using Mass Spectrometry.

  2019cites this paper
• Difference in IgA1 O-glycosylation between IgA deposition donors and IgA nephropathy recipients.

  2019cites this paper
• A Rare Genetic Defect of MBL2 Increased the Risk for Progression of IgA Nephropathy

  2019cites this paper
• The Emerging Role of Complement Proteins as a Target for Therapy of IgA Nephropathy

  2019cites this paper
• Serum IgA1 shows increased levels of α2,6-linked sialic acid in breast cancer

  2019cites this paper
• Location of glomerular immune deposits, not codeposition of immunoglobulin G, influences definitive renal outcomes in immunoglobulin A nephropathy

  2018cites this paper
• Biomarkers for IgA nephropathy on the basis of multi-hit pathogenesis

  2018cites this paper
• Genetics of immunoglobulin-A vasculitis (Henoch-Schönlein purpura): An updated review.

  2018cites this paper
• Mass spectrometry-based approach for development of biomarkers in IgA nephropathy: a pilot trial

  2018cites this paper
• Galactose-Deficient IgA1-Specific Antibody Recognizes GalNAc-Modified Unique Epitope on Hinge Region of IgA1

  2018cites this paper
• Aberrant Glycosylation of the IgA1 Molecule in IgA Nephropathy.

  2018cites this paper
• Assay for galactose-deficient IgA1 enables mechanistic studies with primary cells from IgA nephropathy patients

  2018cites this paper
• The Emerging Role of Pathogenesis of IgA Nephropathy

  2018cites this paper
• Expression of immunoglobulin A in human mesangial cells and its effects on cell apoptosis and adhesion

  2018cites this paper
• Noninvasive biomarkers in IgA nephropathy

  2018cites this paper
• Genetic Determinants of IgA Nephropathy: Western Perspective.

  2018cites this paper
• Inhibition of STAT3 Signaling Reduces IgA1 Autoantigen Production in IgA Nephropathy

  2017cites this paper
• Serial Galactose-Deficient IgA1 Levels in Children with IgA Nephropathy and Healthy Controls

  2017cites this paper
• Toll-Like Receptor 9 Stimulation Induces Aberrant Expression of a Proliferation-Inducing Ligand by Tonsillar Germinal Center B Cells in IgA Nephropathy.

  2017cites this paper
• Identification of novel molecular signatures of IgA nephropathy through an integrative -omics analysis

  2017cites this paper
• New insights in the pathogenesis of immunoglobulin A vasculitis (Henoch-Schönlein purpura).

  2017cites this paper
• Pathophysiology of IgA Nephropathy.

  2017cites this paper
• New insights into the pathogenesis of IgA nephropathy

  2017cites this paper
• Immunopathology of the Urinary System

  2017cites this paper
• Progress of O -glycoprotein and O -glycoproteome analysis in secretion systems

  2017cites this paper
• Immunoglobulin A nephropathy: a pathophysiology view

  2016cites this paper
• Evidence-based clinical practice guidelines for IgA nephropathy 2014

  2016cites this paper
• Chapter 4 Heterogeneity of Aberrant O-Glycosylation of IgA 1 in IgA Nephropathy

  2016cites this paper
• IgA Structure Variations Associate with Immune Stimulations and IgA Mesangial Deposition.

  2016cites this paper
• Ο ρόλος της ελλιπούς γαλακτοζυλίωσης της IgA1 ανοσοσφαιρίνης στην παθογένεια κλινική εικόνα και εξέλιξη της IgA νεφροπάθειας

  2016cites this paper
• Heterogeneity of Aberrant O-Glycosylation of IgA1 in IgA Nephropathy

  2016cites this paper
• Markers for the progression of IgA nephropathy

  2016cites this paper
• CiRCULATiNG igA-CONTAiNiNG iMMUNe COMPLeXeS iN igA NePHROPATHY AND HeNOCH – SCHÖNLeiN PURPURA NePHRiTiS

  2016influential citation
• IgA nephropathy

  2016influential citation
• Aberrant IgA1 Glycosylation in IgA Nephropathy: A Systematic Review

  2016cites this paper
• IgA nephropathy enigma.

  2016cites this paper
• Aberrantly methylated DNA regions lead to low activation of CD4+ T-cells in IgA nephropathy.

  2016cites this paper
• The Origin and Activities of IgA1-Containing Immune Complexes in IgA Nephropathy

  2016influential citation
• Genomic Methods in the Diagnosis and Treatment of Pediatric Kidney Disease

  2015cites this paper
• N-acetylgalactosaminide α2,6-sialyltransferase II is a candidate enzyme for sialylation of galactose-deficient IgA1, the key autoantigen in IgA nephropathy.

  2015cites this paper
• New Insights into the Pathogenesis of IgA Nephropathy

  2015cites this paper
• La nefropatía IgA, la glomerulopatía más frecuente en el mundo

  2015cites this paper
• Henoch–Schönlein purpura nephritis

  2015cites this paper
• Paradigm shift in activity assessment of IgA nephropathy – optimizing the next generation of diagnostic and therapeutic maneuvers via glycan targeting

  2015cites this paper
• IgA Nephropathy and Related Diseases

  2015influential citation
• Association between C1GALT1 variants and genetic susceptibility to IgA nephropathy in Uygur.

  2015cites this paper
• Novel lectin-independent approach to detect galactose-deficient IgA1 in IgA nephropathy

  2015influential citation
• Henoch-Schönlein purpura nephritis in children: incidence, pathogenesis and management

  2015cites this paper